GSK plc
$50.45
−0.19 (−0.38%) · delayed · Nov 13, 2026
Five-year price
52w $45.81 to $61.70
- Market cap
- $217.7B
- Enterprise value
- —
- P/E
- —
- EV / EBIT
- —
- FCF yield
- —
- ROIC
- —
- Debt / equity
- —
- Piotroski F
- —
Value scorecard · FY
Does it pass the value tests?
No XBRL financial data on file for this registrant.
Valuation lab
What do you have to believe?
A cash-flow valuation isn’t meaningful here: free cash flow is negative or not reported (common for banks, insurers and early-stage companies). Use book value and earnings power instead.
Financial statements
A decade of the record.
No annual XBRL data available.
Who owns it
Superinvestors
Filings wire